Rona, Therapeutics

Rona Therapeutics Announces Breakthrough Data on Potential Annual Dosing RNAi Therapy RN026 Targeting Lipoprotein in The National Lipid Association Scientific Sessions 2025

Veröffentlicht: 07.08.2025 um 18:07 Uhr, prnewswire.co.uk

Rona Therapeutics China New York

en | boerse | 67940022 |